Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Q32 Bio Inc.

    NASDAQ: QTTB · Real-Time Price · USD
    1.51
    -0.04 (-2.58%)
    At close: Jun 27, 2025, 3:59 PM
    1.45
    -3.76%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    Q32 Bio Statistics

    Share Statistics

    Q32 Bio has 12.2M shares outstanding. The number of shares has increased by 2.14% in one year.

    Shares Outstanding

    n/a
    		 12.2M

    Shares Change (YoY)

    n/a
    		 2.14%

    Shares Change (QoQ)

    n/a
    		 0.14%

    Owned by Institutions (%)

    n/a
    		 90.09%

    Shares Floating

    n/a
    		 4.44M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,336

    FTD / Avg. Volume

    n/a
    		 1.51%

    Short Selling Information

    The latest short interest is 459.62K, so 3.77% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 459.62K

    Short % of Shares Out

    n/a
    		 3.77%

    Short % of Float

    n/a
    		 13.39%

    Short Ratio (days to cover)

    n/a
    		 4.47

    Valuation Ratios

    The PE ratio is -0.67 and the forward PE ratio is -0.42. Q32 Bio's PEG ratio is -0.05.

    PE Ratio

    n/a
    		 -0.67

    Forward PE

    n/a
    		 -0.42

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 5.65

    P/FCF Ratio

    n/a
    		 -0.47

    PEG Ratio

    n/a
    		 -0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Q32 Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.97, with a Debt / Equity ratio of 3.33.

    Current Ratio

    n/a
    		 4.97

    Quick Ratio

    n/a
    		 4.97

    Debt / Equity

    n/a
    		 3.33

    Debt / EBITDA

    n/a
    		 -0.42

    Debt / FCF

    n/a
    		 -0.28

    Interest Coverage

    n/a
    		 -220.34

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,704,750

    Employee Count

    n/a
    		 28

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 21K

    Effective Tax Rate

    n/a
    		 -0.05%

    Stock Price Statistics

    The stock price has increased by -89.7% in the last 52 weeks. The beta is -0.03, so Q32 Bio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.03

    52-Week Price Change

    n/a
    		 -89.7%

    50-Day Moving Average

    n/a
    		 1.72

    200-Day Moving Average

    n/a
    		 15.12

    Relative Strength Index (RSI)

    n/a
    		 40.37

    Average Volume (20 Days)

    n/a
    		 154,446

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -487K

    Operating Income

    n/a
    		 -66.1M

    Net Income

    n/a
    		 -47.73M

    EBITDA

    n/a
    		 -45.3M

    EBIT

    n/a
    		 -45.79M

    Earnings Per Share (EPS)

    n/a
    		 -5.12
    Full Income Statement

    Balance Sheet

    The company has 77.97M in cash and 18.9M in debt, giving a net cash position of 59.06M.

    Cash & Cash Equivalents

    n/a
    		 77.97M

    Total Debt

    n/a
    		 18.9M

    Net Cash

    n/a
    		 59.06M

    Retained Earnings

    n/a
    		 -234.81M

    Total Assets

    n/a
    		 92.33M

    Working Capital

    n/a
    		 65.41M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -67.72M and capital expenditures -75K, giving a free cash flow of -67.79M.

    Operating Cash Flow

    n/a
    		 -67.72M

    Capital Expenditures

    n/a
    		 -75K

    Free Cash Flow

    n/a
    		 -67.79M

    FCF Per Share

    n/a
    		 -7.27
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    QTTB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for QTTB is $12, which is 664.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 664.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 26, 2024. It was a backward split with a ratio of 1:18.

    Last Split Date

    n/a
    		 Mar 26, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:18

    Scores

    Altman Z-Score

    n/a
    		 -4.16

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist